热门资讯> 正文
CASI Pharmaceuticals宣布任命首席执行官
2025-07-22 04:21
- 英创远达制药(CASI) 0
- 塞拉尼斯(CE) 0
- 纳比特(NA) 0
- CASI Pharmaceuticals (NASDAQ:CASI) has named David Cory as its new chief executive officer and board member.
- Wei-Wu He, Ph.D., will step down as CEO and transition to the role of executive chairman of the board.
- Cory previously served as CEO of LIB Therapeutics, leading Phase 3 trials and a regulatory filing for a cardiovascular therapy.
- CASI shares up 3.3% post-market on Monday.
- Source: Press release
More on CASI Pharmaceuticals
- Seeking Alpha’s Quant Rating on CASI Pharmaceuticals
- Historical earnings data for CASI Pharmaceuticals
- Financial information for CASI Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
